The Dish’s Weekly Biotechnology News Wrap Up – September 28, 2018

This week’s headlines include: Novartis strikes deal with Chinese firm to make Kymriah, Gene tweak kills whole population of malaria-carrying mosquitoes in lab, Congratulations. Your Study Went Nowhere, Gilead to Make Generic Hepatitis C Drugs and Cut Prices Up to 75%, With new blood test, Roche dives deeper into personal cancer care, and T-cell therapy for eradicating HIV reservoirs proves safe in small study.


Check out our podcast channel. We have over 20 great podcasts covering drug discovery, stem cell culture, upstream and downstream biomanufacturing and more! Click below to download from iTunes or Google play:
Available on Google PlayAvailable on itunes


Upcoming Conferences


25-26 October 2018, Novotel London West Hotel, London, UK

The annual Cell Series features 4 outstanding programmes: our long-running 7th Cell Culture and Bioprocessing, 5thStem Cell & Regenerative Medicine, 4th Cell and Gene Therapy and Biobanking Congresses. The Cell Series provides a focused networking platform targeting Cell Culture & Cell Line Development and Bioprocessing; Cell & Gene Therapy highlighting CAR T Cell Development; Stem Cell & Regeneration Medicine Development as well as Biobanking.

Pin It on Pinterest